Toxoplasma gondii (T. gondii) an intracellular protozoan parasite, infects mammals including human population world-wide. Upon primary infection, the parasite contributes to mild flu like symptoms in immune competent host, but life threatening complication is seen in immune compromised patients and in pregnant women. Understanding the host-parasite interaction is critical for understanding the pathogenesis and biology parasite reactivation in the host. In this study, we used proteotrasncriptomics analyses by integrating the transcriptomics and proteomics data of T. gondii infected mouse liver to uncover the effector molecules responsible for disease pathogenesis that can be used as candidate markers for diagnosis and drug target. With this aim, we systematically integrated transcriptomicand proteomic data, representing the parasite infected mouse liver. Out of 2758 differentially expressed genes (DEGs) and 301 differentially expressed proteins (DEPs), 159 overlapping genes were identified. Among them, 86 genes were upregulated and 72 were downregulated in their respective mRNA and protein levels in the infected condition. Gene Ontology (GO) analysis revealed that the upregulated genes were mostly associated with immune system processes whereas the downregulated genes were involved in oxidation-reduction process and metabolism of lipid, and fatty acids. Protein-protein interaction (PPI) network analysis uncovered an interaction-hub including, Psmb8, Psmb9 and Tap1 for upregulated proteins and Cyp1A2, Cyp4A10 and Cyp3A11 for down-regulated proteins. Further studies are needed to validating these effector molecules. These molecules are likely to play a vital role in disease pathogenesis, as well as can be used as potential diagnostic marker and drug target candidates.
References
[1]
Flegr, J., Prandota, J., Sovičková, M. and Israili, Z.H. (2014) Toxoplasmosis—A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries. PLoS ONE, 9, e90203.
https://doi.org/10.1371/journal.pone.0090203
[2]
Innes, E.A. and Innes, E.A. (2009) A Brief History and Overview of Toxoplasma gondii. Zoonoses and Public Health, 57, 1-7.
https://doi.org/10.1111/j.1863-2378.2009.01276.x
[3]
Hussain, M.A., Stitt, V., Szabo, E.A. and Nelan, B. (2017) Toxoplasma gondii in the Food Supply. Pathogens (Basel, Switzerland), 6, 21.
https://doi.org/10.3390/pathogens6020021
[4]
Pappas, G., Roussos, N. and Falagas, M.E. (2009) Toxoplasmosis Snapshots: Global Status of Toxoplasma gondii Seroprevalence and Implications for Pregnancy and Congenital Toxoplasmosis. International Journal for Parasitology, 39, 1385-1394.
https://doi.org/10.1016/j.ijpara.2009.04.003
[5]
Andiappan, H., et al. (2014) Toxoplasma Infection in Pregnant Women: A Current Status in Songklanagarind Hospital, Southern Thailand. Parasites & Vectors, 7, Article No. 239. https://doi.org/10.1186/1756-3305-7-239
[6]
Räisänen, S. (1978) Toxoplasmosis Transmitted by Blood Transfusions. Transfusion, 18, 329-332. https://doi.org/10.1046/j.1537-2995.1978.18378205142.x
[7]
Wreghitt, T.G., et al., (1989) Toxoplasmosis in Heart and Heart and Lung Transplant Recipients. Journal of Clinical Pathology, 42, 194-199.
https://doi.org/10.1136/jcp.42.2.194
[8]
Montoya, J.G. and Liesenfeld, O. (2004) Toxoplasmosis. The Lancet, 363, 1965-1976.
https://doi.org/10.1016/S0140-6736(04)16412-X
[9]
Dubey, J.P., Lindsay, D.S. and Speer, C.A. (1998) Structures of Toxoplasma gondii Tachyzoites, Bradyzoites, and Sporozoites and Biology and Development of Tissue Cysts. Clinical Microbiology Reviews, 11, 267.
https://doi.org/10.1128/CMR.11.2.267
[10]
Tenter, A.M., Heckeroth, A.R. and Weiss, L.M. (2000) Toxoplasma gondii: From Animals to Humans. International Journal for Parasitology, 30, 1217-1258.
https://doi.org/10.1016/S0020-7519(00)00124-7
[11]
Manlio, et al. (2008) Temporal and Spatial Distribution of Toxoplasma gondii Differentiation into Bradyzoites and Tissue Cyst Formation in Vivo. Infection and Immunity, 76, 3491-3501. https://doi.org/10.1128/IAI.00254-08
[12]
Kadarisman, R.S., Marsetio, M. and Simangunsong, L.B. (1991) Visual Impairment and Blindness in Ocular. The Southeast Asian Journal of Tropical Medicine and Public Health, 9, 99-101.
[13]
Khurana, S. and Batra, N. (2016) Toxoplasmosis in Organ Transplant Recipients: Evaluation, Implication, and Prevention. Tropical Parasitology, 6, 123-128.
https://doi.org/10.4103/2229-5070.190814
[14]
Alvarado-Esquivel, C., Torres-Berumen, J.L., Estrada-Martínez, S., Liesenfeld, O. and Mercado-Suarez, M.F. (2011) Toxoplasma gondii Infection and Liver Disease: A Case-Control Study in a Northern Mexican Population. Parasites & Vectors, 4, 75. https://doi.org/10.1186/1756-3305-4-75
[15]
Alamri, Z.Z. (2018) The Role of Liver in Metabolism: An Updated Review with Physiological Emphasis. International Journal of Basic & Clinical Pharmacology, 7, 2271-2276. https://doi.org/10.18203/2319-2003.ijbcp20184211
[16]
Ustun, S., Aksoy, U., Dagci, H. and Ersoz, G. (2004) Incidence of Toxoplasmosis in Patients with Cirrhosis. World Journal of Gastroenterology, 10, 452-454.
https://doi.org/10.3748/wjg.v10.i3.452
[17]
He, J.-J. (2016) Transcriptomic Analysis of Mouse Liver Reveals a Potential Hepato-Enteric Pathogenic Mechanism in Acute Toxoplasma gondii Infection. Parasites & Vectors, 9, 427. https://doi.org/10.1186/s13071-016-1716-x
[18]
He, J.-J., Ma, J., Elsheikha, H.M., Song, H.-Q., Zhou, D.-H. and Zhu, X.-Q. (2016) Proteomic Profiling of Mouse Liver Following Acute Toxoplasma gondii Infection. PLoS ONE, 11, e0152022. https://doi.org/10.1371/journal.pone.0152022
[19]
Schwanhüusser, B., et al. (2011) Global Quantification of Mammalian Gene Expression Control. Nature, 473, 337-342. https://doi.org/10.1038/nature10098
[20]
Tiwari, I., Rolland, C.F., et al. (1982) Cholestatic Jaundice due to Toxoplasma Hepatitis. Postgraduate Medical Journal, 58, 299-300.
https://doi.org/10.1136/pgmj.58.679.299
[21]
Blader, I.J. and Saeij, J.P. (2009) Communication between Toxoplasma gondii and Its Host: Impact on Parasite Growth, Development, Immune Evasion, and Virulence. Apmis, 117, 458-476. https://doi.org/10.1111/j.1600-0463.2009.02453.x
[22]
Nelson, M.M., et al. (2008) Modulation of the Host Cell Proteome by the Intracellular Apicomplexan Parasite Toxoplasma gondii. Infection and Immunity, 76, 828-844.
https://doi.org/10.1128/IAI.01115-07
[23]
Zhou, D.-H., et al. (2013) Changes in the Proteomic Profiles of Mouse Brain after Infection with Cyst-Forming Toxoplasma gondii. Parasites & Vectors, 6, Article No. 96. https://doi.org/10.1186/1756-3305-6-96
[24]
Zhou, C.X., Elsheikha, H.M., Zhou, D.H., Liu, Q., Zhu, X.Q. and Suo, X. (2016) Dual Identification and Analysis of Differentially Expressed Transcripts of Porcine PK-15 Cells and Toxoplasma gondii during in Vitro Infection. Frontiers in Microbiology, 7, 1-13. https://doi.org/10.3389/fmicb.2016.00721
[25]
Iskar, M., et al. (2013) Characterization of Drug-Induced Transcriptional Modules: Towards Drug Repositioning and Functional Understanding. Molecular Systems Biology, 9, 662. https://doi.org/10.1038/msb.2013.20
[26]
Lee, I., Lehner, B., Vavouri, T., Shin, J., Fraser, A.G. and Marcotte, E.M. (2010) Predicting Genetic Modifier Loci Using Functional Gene Networks. Genome Research, 20, 1143-1153. https://doi.org/10.1101/gr.102749.109
[27]
Sharan, R., Ulitsky, I. and Shamir, R. (2007) Network-Based Prediction of Protein Function. Molecular Systems Biology, 3, 1-13. https://doi.org/10.1038/msb4100129
[28]
Lu, Y., et al. (2019) Identification of Differentially Expressed Genes and Signaling Pathways Using Bioinformatics in Interstitial Lung Disease due to Tyrosine Kinase Inhibitors Targeting the Epidermal Growth Factor Receptor. Investigational New Drugs, 37, 384-400. https://doi.org/10.1007/s10637-018-0664-z
[29]
Tu, L., et al. (2009) Critical Role for the Immunoproteasome Subunit LMP7 in the Resistance of Mice to Toxoplasma gondii Infection. European Journal of Immunology, 39, 3385-3394. https://doi.org/10.1002/eji.200839117
[30]
Möhle, L., et al. (2016) Chronic Toxoplasma gondii Infection Enhances β-Amyloid Phagocytosis and Clearance by Recruited Monocytes. Acta Neuropathologica Communications, 4, 25. https://doi.org/10.1186/s40478-016-0293-8
[31]
Goldszmid, R.S., et al. (2007) TAP-1 Indirectly Regulates CD4+ T Cell Priming in Toxoplasma gondii Infection by Controlling NK Cell IFN-γ Production. Journal of Experimental Medicine, 204, 2591-2602. https://doi.org/10.1084/jem.20070634
[32]
He, J.J., et al. (2016) Transcriptomic Analysis of Global Changes in Cytokine Expression in Mouse Spleens Following Acute Toxoplasma gondii Infection. Parasitology Research, 115, 703-712. https://doi.org/10.1007/s00436-015-4792-5
[33]
Martens, S., et al. (2005) Disruption of Toxoplasma gondii Parasitophorous Vacuoles by the Mouse p47-Resistance GTPases. PLOS Pathogens, 1, e24.
https://doi.org/10.1371/journal.ppat.0010024
[34]
Degrandi, D., et al. (2013) Murine Guanylate Binding Protein 2 (mGBP2) Controls Toxoplasma gondii Replication. Proceedings of the National Academy of Sciences of the United States of America, 110, 294-299.
https://doi.org/10.1073/pnas.1205635110
[35]
Collazo, C.M., et al. (2001) Inactivation of LRG-47 and IRG-47 Reveals a Family of Interferon γ-Inducible Genes with Essential, Pathogen-Specific Roles in Resistance to Infection. Journal of Experimental Medicine, 194, 181-187.
https://doi.org/10.1084/jem.194.2.181
[36]
Taylor, G.A., et al. (2000) Pathogen-Specific Loss of Host Resistance in Mice Lacking the IFN-γ-Inducible Gene IGTP. Proceedings of the National Academy of Sciences of the United States of America, 97, 751-755. https://doi.org/10.1073/pnas.97.2.751
[37]
Wang, Z.C., et al. (2008) Regulation of Innate Immune Responses by DAI (DLM-1/ ZBP1) and Other DNA-Sensing Molecules. Proceedings of the National Academy of Sciences of the United States of America, 105, 5477.
https://doi.org/10.1073/pnas.0801295105
[38]
Chuang, H.Y., Lee, E., Liu, Y.T., Lee, D. and Ideker, T. (2007) Network-Based Classification of Breast Cancer Metastasis. Molecular Systems Biology, 3, 140.
https://doi.org/10.1038/msb4100180
[39]
Ideker, T., Ozier, O., Schwikowski, B. and Siegel, A.F. (2002) Discovering Regulatory and Signalling Circuits in Molecular Interaction Networks. Bioinformatics, 18, 233-240. https://doi.org/10.1093/bioinformatics/18.suppl_1.S233
[40]
He, X. and Zhang, J. (2006) Why Do Hubs Tend to Be Essential in Protein Networks? PLOS Genetics, 2, e88. https://doi.org/10.1371/journal.pgen.0020088
[41]
Jeong, H., Mason, S.P., Barabási, A.L. and Oltvai, Z.N. (2001) Lethality and Centrality in Protein Networks. Nature, 411, 41-42. https://doi.org/10.1038/35075138
[42]
Albert, R., Jeong, H. and Barabási, A.L. (2000) Error and Attack Tolerance of Complex Networks. Nature, 406, 378-382. https://doi.org/10.1038/35019019
[43]
Han, J.D.J., et al. (2004) Evidence for Dynamically Organized Modularity in the Yeast Protein-Protein Interaction Network. Nature, 430, 88-93.
https://doi.org/10.1038/nature02555
[44]
Lee, D.S., Park, J., Kay, K.A., Christakis, N.A., Oltvai, Z.N. and Barabási, A.L. (2008) The Implications of Human Metabolic Network Topology for Disease Comorbidity. Proceedings of the National Academy of Sciences of the United States of America, 105, 9880-9885. https://doi.org/10.1073/pnas.0802208105
